Endophytic fungi in rice pudding fruit and its application

By screening and preserving the endophytic fungi of Micao fruit Diaporthe sp.MGF21 and MGF29, the problem of resource supply was solved, and metabolites and volatile oils similar to fruit volatile oils were obtained, which were used to prepare antipathogenic bacteria and therapeutic drugs, achieving high efficiency of resources Utilization and treatment effects.

CN118006467BActive Publication Date: 2024-11-19GUIZHOU UNIV +3
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311765236.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-21
Publication Date
2024-11-19
Estimated Expiration
2043-12-21

AI Technical Summary

Technical Problem

The resource supply of Micao fruits is tight, and it is difficult for the existing technology to quickly obtain ingredients similar to volatile oils of Micao fruits, resulting in insufficient resource supply.

Method used

The endophyte fungi Diaporthe sp.MGF21 and Diaporthe sp.MGF29 were screened and preserved. The endophytes of Micao fruits were obtained by culturing these fungi to obtain their metabolites and volatile oils, which were used to prepare anti-pathogenic bacteria and drugs for the treatment of gastrointestinal and cardiovascular and cerebrovascular diseases.

Benefits of technology

It effectively alleviates the shortage of Micao's fruit resource supply, obtains ingredients similar to volatile oils through endophytic fungi, has significant antibacterial activity and therapeutic effects, has antagonistic effects on a variety of plant pathogens, and is used to prepare drugs with therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118006467B_ABST
    Figure CN118006467B_ABST
Patent Text Reader

Abstract

The invention discloses endophytic fungi of Migao fruit and application thereof. The endophytic fungi Diaporthe sp.MGF21 and Diaporthe sp.MGF29 described in the invention belong to new species of the genus Diaporthe, the main components of the volatile oil of the strain are consistent with those of Migao fruit, and have good antibacterial activity against Neofusicoccum sp.LH107, Neofusicoccum parvum, Botryosphaeria dothidea and Fusarium sp.YYH2005.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomedicine, and particularly relates to endophytic fungi in rice pudding fruit and applications thereof. Background Art

[0002] Cinnamomum migao HWLi is an evergreen tall tree of the Lauraceae family. It is listed as a near threatened (NT) species in the Red List of Higher Plants of China and is mainly distributed in the border areas of Guizhou, Guangxi, and Yunnan in my country. The volatile oil in its fruit has excellent therapeutic effects in the treatment of gastrointestinal diseases and cardiovascular and cerebrovascular diseases. Currently, 4 finished Chinese patent medicines have been developed and marketed (the dominant rhizosphere microbial communities that affect the main components of migao at different fruiting stages and their response to soil properties, the diversity analysis of the phenotypic characteristics of migao fruits and seeds of different populations, and the ethnic medicinal plant of Guizhou - migao).

[0003] At present, the fruit resources of Migao mainly rely on wild ones, but the germination rate of Migao seeds is low, and the fruiting period of artificial cultivation is as long as 8-10 years. At present, the contradiction of its fruit resource supply is extremely prominent. How to alleviate the problem of tight resource supply is an important problem at present.

[0004] Therefore, it is necessary to quickly obtain components similar to the volatile oil of Migao fruit and replace them to alleviate the supply of Migao fruit resources. Many research results on medicinal plants have shown that endophytic fungi inhabiting plants will produce the same metabolites as the host during the long-term co-evolution between the host and the endophytic fungi. The isolation and screening of strains producing target metabolites, coupled with the advantages of microorganisms in cultivation and fermentation, will help to obtain the target products on an industrial and large-scale basis. Therefore, it is necessary to carry out the screening of endophytic fungi that produce volatile oils of similar fruit components and obtain endophytic fungi that effectively produce volatile oils with similar components to Migao fruit in order to alleviate the pressure on its resource supply. Summary of the invention

[0005] In order to make up for the deficiencies of the prior art, the present invention provides endophytic fungi in rice pudding fruit and applications thereof.

[0006] To achieve the above object, the present invention adopts the following technical solution:

[0007] A first aspect of the present invention provides endophytic fungi of Migao fruit, which are deposited in China Center for Type Culture Collection, including strain Diaporthe sp.MGF21 with a deposit number of CCTCC NO: M 20231458 and strain Diaporthe sp.MGF29 with a deposit number of CCTCC NO: M 20231459.

[0008] Furthermore, the nucleotide sequence of strain Diaporthe sp. MGF21 is shown in SEQ ID NO:1.

[0009] Furthermore, the nucleotide sequence of strain Diaporthe sp.MGF29 is shown in SEQ ID NO:2.

[0010] A second aspect of the present invention provides a culture comprising the endophytic fungus according to the first aspect of the present invention.

[0011] The third aspect of the present invention provides a reagent comprising the endophytic fungus or its metabolite according to the first aspect of the present invention or the culture according to the second aspect of the present invention.

[0012] The fourth aspect of the present invention provides an agricultural drug for resisting pathogenic bacteria comprising the endophytic fungus or its metabolite according to the first aspect of the present invention, the culture according to the second aspect of the present invention, or the agent according to the third aspect of the present invention.

[0013] Furthermore, the pathogenic bacteria include one or more of Neofusicoccum parvum, Botryosphaeria dothidea, Fusarium sp.YYH2005 or Neofusicoccum sp.LH107.

[0014] Furthermore, the pathogenic bacteria are selected from plant pathogenic bacteria.

[0015] Furthermore, the plant is selected from the genus Cinnamomum of the Lauraceae family.

[0016] Furthermore, the plant of the genus Cinnamomum in the family Lauraceae is selected from Rhizoma Corydalis.

[0017] Furthermore, the migao is migao fruit.

[0018] Furthermore, the agricultural drug also includes an agriculturally acceptable carrier.

[0019] Furthermore, the agricultural drug can also be used in combination with other pesticides.

[0020] The fifth aspect of the present invention provides a volatile oil, which is prepared from the endophytic fungus or its metabolite according to the first aspect of the present invention or the culture according to the second aspect of the present invention.

[0021] Furthermore, the components of the volatile oil include one or more of α-pinene, 1,8-cineole, elemenol or α-terpineol.

[0022] The sixth aspect of the present invention provides a medicine, which comprises the endophytic fungus or its metabolite according to the first aspect of the present invention, the culture according to the second aspect of the present invention, or the volatile oil according to the fifth aspect of the present invention.

[0023] Furthermore, the components of the volatile oil include one or more of α-pinene, 1,8-cineole, elemenol or α-terpineol.

[0024] Furthermore, the drug also includes a pharmaceutically acceptable carrier.

[0025] A seventh aspect of the present invention provides any of the following applications:

[0026] (1) Use of the endophytic fungus or its metabolites according to the first aspect of the present invention or the culture according to the second aspect of the present invention in the preparation of volatile oil;

[0027] (2) Use of the endophytic fungus or its metabolites according to the first aspect of the present invention or the culture according to the second aspect of the present invention in resisting pathogenic bacteria or in preparing an agent for resisting pathogenic bacteria;

[0028] (3) Use of the endophytic fungus or its metabolites according to the first aspect of the present invention, the culture according to the second aspect of the present invention, or the volatile oil according to the fifth aspect of the present invention in the preparation of a drug for treating gastrointestinal diseases or cardiovascular and cerebrovascular diseases.

[0029] Furthermore, the components of the volatile oil described in (1) include one or more of α-pinene, 1,8-cineole, elemenol or α-terpineol.

[0030] Furthermore, the pathogenic bacteria described in (2) include one or more of Neofusicoccum parvum, Botryosphaeriadothidea, Fusarium sp.YYH2005 or Neofusicoccum sp.LH107.

[0031] Furthermore, the pathogenic bacteria described in (2) is selected from plant pathogenic bacteria.

[0032] Furthermore, the plant is selected from the genus Cinnamomum of the Lauraceae family.

[0033] Furthermore, the plant of the genus Cinnamomum in the family Lauraceae is selected from Rhizoma Corydalis.

[0034] Furthermore, the migao is migao fruit.

[0035] Furthermore, the gastrointestinal diseases described in (3) include gastritis, gastric ulcer, and enteritis.

[0036] Furthermore, the cardiovascular and cerebrovascular diseases mentioned in (3) include coronary heart disease, myocardial infarction, hypertension, hyperlipidemia, cerebral infarction, cerebral hemorrhage, atherosclerosis, and cerebral infarction.

[0037] The eighth aspect of the present invention provides a method for preparing the endophytic fungus according to the first aspect of the present invention, the method comprising: inoculating the Migao fruit on a fungal culture medium for culturing.

[0038] Furthermore, the fungal culture medium is PDA culture medium.

[0039] Furthermore, the culture condition for culturing the Migao fruit inoculated on the fungal culture medium is a constant temperature culture at 28°C.

[0040] Furthermore, the rice-gone-fruit is a rice-gone-fruit tissue block.

[0041] Furthermore, the Migao fruit tissue block is obtained by sterilizing the Migao fruit and cutting it into pieces.

[0042] Furthermore, the Migao fruit tissue block is a tissue block of 1-2 cm.

[0043] Furthermore, the method for disinfecting the rice husk fruit includes soaking it in alcohol and effective chlorine.

[0044] Furthermore, the alcohol is 75% alcohol.

[0045] Furthermore, the available chlorine is 5% available chlorine.

[0046] The ninth aspect of the present invention provides a method for inhibiting pathogenic bacteria, the method comprising applying the endophytic fungus or its metabolite described in the first aspect of the present invention, the culture described in the second aspect of the present invention, the reagent described in the third aspect of the present invention, or the agricultural drug described in the fourth aspect of the present invention.

[0047] Furthermore, the pathogenic bacteria include one or more of Neofusicoccum parvum, Botryosphaeria dothidea, Fusarium sp.YYH2005 or Neofusicoccum sp.LH107.

[0048] Furthermore, the pathogenic bacteria are selected from plant pathogenic bacteria.

[0049] Furthermore, the plant is selected from the genus Cinnamomum of the Lauraceae family.

[0050] Furthermore, the plant of the genus Cinnamomum in the family Lauraceae is selected from Rhizoma Corydalis.

[0051] Furthermore, the migao is migao fruit.

[0052] Deposit information of biological materials:

[0053] 1. Classification and nomenclature: Diaporthe sp.MGF21;

[0054] Depository: China Center for Type Culture Collection (CCTCC);

[0055] Storage address: No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province;

[0056] Deposit date: August 14, 2023;

[0057] Deposit number: CCTCC NO: M 20231458;

[0058] 2. Classification and nomenclature: Diaporthe sp.MGF29;

[0059] Depository: China Center for Type Culture Collection (CCTCC);

[0060] Storage address: No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province;

[0061] Deposit date: August 14, 2023;

[0062] Deposit number: CCTCC NO: M 20231459.

[0063] Advantages and beneficial effects of the present invention:

[0064] The endophytic fungi Diaporthe sp.MGF21 and Diaporthe sp.MGF29 described in the present invention belong to new species of the genus Diaporthe, the main components of the volatile oil of the strains are consistent with those of the fruit of Migao, and have good antibacterial activity against Neofusicoccum sp.LH107 (MGF1002), Neofusicoccum parvum (MGF1003), Botryosphaeriadothidea (MGF1004) and Fusarium sp.YYH2005 (MGF1005). BRIEF DESCRIPTION OF THE DRAWINGS

[0065] Figure 1 The colony and hyphae images of the endophytic fungi MGF21 and MGF29 in the fruit of Migao, among which 1A is the colony morphology of MGF21, 1B is the microscopic image of the hyphae of MGF21, 1C is the colony morphology of MGF29, and 1D is the microscopic image of the hyphae of MGF29;

[0066] Figure 2 This is the phylogenetic tree of endophytic fungi MGF21 and MGF29 in Migao fruit;

[0067] Figure 3 The GC-MS total ion chromatogram of endophytic fungi MGF21, MGF29 and volatile oil from Migao fruit;

[0068] Figure 4 These are the confrontation diagrams between the endophytic fungi MGF21 and MGF29 in the fruit of rice pudding and the pathogens, among which, 4A is the antagonistic result diagram of MGF21 and Neofusicoccum parvum (MGF1003), 4B is the antagonistic result diagram of MGF21 and Botryosphaeria dothidea (MGF1004), 4C is the antagonistic result diagram of MGF21 and Fusarium sp. YYH2005 (MGF1005), 4D is the antagonistic result diagram of MGF29 and Neofusicoccum parvum (MGF1003), 4E is the antagonistic result diagram of MGF29 and Botryosphaeria dothidea (MGF1004), and 4F is the antagonistic result diagram of MGF29 and Fusarium sp. YYH2005 (MGF1005). DETAILED DESCRIPTION

[0069] The definitions of some terms used in this specification are provided below. Unless otherwise defined, all technical and scientific terms used herein generally have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0070] The invention provides endophytic fungi of rice pudding fruit. The endophytic fungi are deposited in China Center for Type Culture Collection and include strain Diaporthe sp.MGF21 with a deposit number of CCTCC NO: M 20231458 and strain Diaporthe sp.MGF29 with a deposit number of CCTCC NO: M 20231459.

[0071] In one embodiment of the present invention, endophytic fungi are fungi that can infect and colonize healthy plant tissues for at least part of their life cycle, and the host has no obvious symptoms (Petrini, 1991; Wilson, 1995). Unlike mycorrhizal fungi that only exist in plant roots, endophytic fungi can exist in any tissue or organ of the underground and aboveground parts of the plant (Faeth & Fagan, 2002). Endophytic fungi are widely present in plant tissues, are not affected by the external environment, and have a wide range of biological effects on plant growth and development, resistance to diseases and insect pests, etc., and are also of great significance in the wide application of some plants and crops.

[0072] Endophytic fungi are mainly distributed in the seeds, flowers, stems, leaves and roots of plants. They have a mutually beneficial symbiotic relationship with plants. In addition, endophytic fungi can provide photosynthetic products and minerals. The metabolites of endophytic fungi can stimulate the growth and development of host plants and improve the host plants' resistance to biotic and abiotic stresses. That is, there is a circulation and exchange of matter and energy between the two. The positive growth-promoting effect of endophytic fungi on host plants is partly the result of the effects of active substances or secondary metabolites secreted by endophytic fungi on plant growth.

[0073] The colonies of Diaporthe sp.MGF21 and Diaporthe sp.MGF29 on PDA plate medium were off-white in the early stage and then turned yellow. The hyphae were dense and flocculent, the matrix was off-white, and they grew rapidly. Based on the morphological characteristics of hyphae and spore characteristics, the two endophytic fungi MGF21 and MGF29 in the fruit of Migao belonged to the new species of Diaporthe.

[0074] The present invention provides a culture comprising the above-mentioned endophytic fungus.

[0075] The culture is preferably an isolated or substantially purified culture.

[0076] In one embodiment of the present invention, an isolated culture or substantially purified culture refers to a culture of the strain of the present invention that does not include significant amounts of other substances that are usually found in the natural habitat where the strain grows and / or the strain is usually available from. Thus, such an isolated culture or substantially purified culture is at least 60% free, preferably at least 75% free, and more preferably at least 90% free, even more preferably at least 95% free and most preferably at least 99% free of other substances that are usually found in the natural habitat where the strain grows and / or the strain is usually available from. Such an isolated culture or substantially purified culture generally does not include any other fungi in an amount sufficient to interfere with the replication of the strain of the present invention.

[0077] The present invention provides an agricultural drug for resisting pathogenic bacteria, comprising the endophytic fungus or its metabolites, the culture or the reagent.

[0078] In one embodiment of the present invention, the pathogen may be a plant pathogen existing in a plant, or may be a pathogen in a laboratory or in other forms.

[0079] In a preferred embodiment of the present invention, the pathogen is a plant pathogen existing in plants.

[0080] The plant pathogens include pathogens in any plant. In a more preferred embodiment of the present invention, the plant is selected from the plant of the genus Cinnamomum in the family Lauraceae. In a more preferred embodiment of the present invention, the plant of the genus Cinnamomum in the family Lauraceae is selected from Mi Gao. In a specific embodiment of the present invention, the Mi Gao is the fruit of Mi Gao.

[0081] In one embodiment of the invention, agricultural drugs can be used interchangeably with pesticides, which are chemical or biological agents (such as viruses, bacteria, antimicrobials, or disinfectants) that prevent, disable, kill, or hinder pests through their actions. The term pesticide also includes plant growth regulators that change the expected plant growth, flowering, or reproduction rate; defoliants that cause leaves or other foliage to fall from plants, usually to facilitate harvesting; desiccants that promote the drying of living tissues (such as unwanted plant tops); plant activators that activate the defense physiology of plants against certain pests; safeners that reduce the undesirable herbicidal effects of pesticides on crops; and plant growth promoters that affect plant physiology to increase plant growth, biomass, yield, or any other quality parameter of the harvestable material of the crop.

[0082] The agricultural drug also includes an agriculturally acceptable carrier.

[0083] In one embodiment of the present invention, agriculturally acceptable carriers include, but are not limited to, solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesives, thickeners, wetting agents, repellents, attractants, feeding stimulants, compatibilizers, bactericides, antifreeze agents, defoamers, colorants, tackifiers or adhesives.

[0084] Among them, suitable solvents and liquid carriers include, but are not limited to, water and organic solvents, such as kerosene, diesel; oils of plant or animal origin; aliphatic, cyclic or aromatic hydrocarbons, such as toluene, paraffin, tetralin, alkylated naphthalene; alcohols, such as ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycol; DMSO; ketones, such as cyclohexanone; esters, such as lactic acid esters, carbonates, fatty acid esters, γ-butyrolactone; fatty acids; phosphonates; amines; amides, such as N-methylpyrrolidone, fatty acid dimethylamide; and mixtures thereof.

[0085] Suitable solid carriers or fillers include, but are not limited to, mineral earths, e.g., silicates, silica gel, talc, kaolin, limestone, lime, clay, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g., cellulose, starch; fertilizers, e.g., ammonium sulfate, ammonium phosphate, sodium nitrate, urea; products of plant origin, e.g., grain flour, bark flour, wood flour, nut shell flour, and mixtures thereof.

[0086] Suitable surfactants include, but are not limited to, surface active compounds such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifiers, dispersants, solubilizers, wetting agents, penetration enhancers, protective colloids or adjuvants.

[0087] Suitable anionic surfactants include, but are not limited to, alkali, alkaline earth or ammonium salts of sulfonic acid, sulfuric acid, phosphoric acid, carboxylic acid, and mixtures thereof. The example of sulfonate includes, but is not limited to, alkylaryl sulfonate, biphenyl sulfonate, α-olefin sulfonate, lignin sulfonate, fatty acid and oil sulfonate, ethoxylated alkylphenol sulfonate, alkoxylated arylphenol sulfonate, condensed naphthalene sulfonate, dodecyl- and tridecylbenzene sulfonate, naphthalene and alkylnaphthalene sulfonate, sulfosuccinate or sulfosuccinamates. The example of sulfate includes, but is not limited to, fatty acid and oil sulfate, ethoxylated alkylphenol sulfate, alcohol sulfate, ethoxylated alcohol sulfate, or the sulfate of fatty acid ester. The example of phosphate is phosphate ester. The example of carboxylate includes, but is not limited to, alkyl carboxylates and carboxylated alcohol or alkylphenol ethoxylate.

[0088] Suitable nonionic surfactants include, but are not limited to, alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates include, but are not limited to, compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids, or fatty acid esters, which have been alkoxylated in 1 to 50 equivalents. Ethylene oxide and / or propylene oxide can be used for alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucosamine or fatty acid alkanolamides. Examples of esters include, but are not limited to, fatty acid esters, glycerides, or monoglycerides. Examples of sugar-based surfactants include, but are not limited to, sorbitan, ethoxylated sorbitan, sucrose, and glucose esters or alkyl polyglucosides. Examples of polymeric surfactants include, but are not limited to, homopolymers or copolymers of vinyl pyrrolidone, vinyl alcohol, or vinyl acetate.

[0089] Suitable cationic surfactants include, but are not limited to, quaternary surfactants, for example, quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants include, but are not limited to, alkyl betaines and imidazolines. Suitable block polymers include, but are not limited to, block polymers of AB or ABA type of polyethylene oxide and polypropylene oxide blocks, or block polymers of ABC type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes include, but are not limited to, polyacids or polyalkalis. Examples of polyacids include, but are not limited to, alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polyalkalis include, but are not limited to, polyvinylamine or polyvinylamine.

[0090] Suitable adjuvants are compounds which themselves have negligible or even no pesticidal activity and which enhance the biological performance of the endophytic fungus, culture medium, to the target. Examples include, but are not limited to, surfactants, mineral or vegetable oils, and other adjuvants.

[0091] Suitable thickening agents include, but are not limited to, polysaccharides (eg, xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.

[0092] Suitable bactericides include, but are not limited to, bronopol and isothiazolinone derivatives, such as alkylisothiazolinone and phenylisothiazolinone. Suitable antifreeze agents include, but are not limited to, ethylene glycol, propylene glycol, urea and glycerol. Suitable defoamers include, but are not limited to, silicone, long-chain alcohols and salts of fatty acids. Suitable colorants (e.g., red, blue or green) include, but are not limited to, low water-soluble pigments and water-soluble dyes. Examples include, but are not limited to, inorganic colorants (e.g., iron oxide, titanium oxide, hexacyanoferrate) and organic colorants (e.g., alizarin-, azo- and phthalocyanine colorants). Suitable tackifiers or adhesives include, but are not limited to, polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol, polyacrylate, biological or synthetic waxes and cellulose esters.

[0093] The user usually applies the agricultural drug of the present invention from a pre-dosing device, a backpack sprayer, a spray tank, a spraying aircraft or an irrigation system. Usually, the agrochemical composition is made into the required application concentration with water, a buffer and / or other adjuvants, and thus obtains a spray liquid or an agrochemical composition ready to use according to the present invention.

[0094] The agricultural chemicals may also be used in combination with other pesticides.

[0095] In one embodiment of the present invention, the other pesticides include, but are not limited to, insect control agents, insecticides, fungicides, or combinations thereof.

[0096] The present invention provides a medicine, which comprises the endophytic fungus or its metabolites, the culture or the volatile oil.

[0097] In one embodiment of the present invention, gastrointestinal diseases include gastritis, gastric ulcer, and enteritis.

[0098] Among them, gastritis includes but is not limited to chronic gastritis and acute gastritis.

[0099] Gastric ulcers include, but are not limited to, peptic ulcers, stress ulcers, and bleeding ulcers.

[0100] Enteritis includes, but is not limited to, ulcerative colitis, indeterminate colitis, microscopic colitis, infectious colitis, drug- or chemical-induced colitis, diverticulitis and ischemic colitis, collagenous colitis, eosinophilic gastroenteritis, colitis associated with radiation therapy or chemotherapy, colitis associated with innate immune disorder of leukocyte adhesion deficiency-1, pseudomembranous colitis, hemorrhagic colitis, hemolytic uremic syndrome colitis, and diversion colitis.

[0101] The cardiovascular and cerebrovascular diseases include but are not limited to coronary heart disease, myocardial infarction, hypertension, hyperlipidemia, cerebral infarction, cerebral hemorrhage, atherosclerosis, and cerebral infarction. Among them, hyperlipidemia includes but is not limited to hypercholesterolemia and hypertriglyceridemia.

[0102] The medicament further includes a pharmaceutically acceptable carrier.

[0103] In one embodiment of the present invention, the pharmaceutically acceptable carrier includes, but is not limited to, additives such as stabilizers, bactericides, buffers, isotonic agents, chelating agents, pH control agents, and surfactants.

[0104] Among them, stabilizers include human serum albumin, L-amino acids, sugars and cellulose derivatives. L-amino acids can also include any one of glycine, cysteine ​​and glutamic acid. Carbohydrates include monosaccharides such as glucose, mannose, galactose, fructose, etc.; sugar alcohols such as mannitol, inositol, xylitol, etc.; disaccharides such as sucrose, maltose, lactose, etc.; polysaccharides such as dextran, hydroxypropyl starch, chondroitin sulfate, hyaluronic acid, etc. and their derivatives. Cellulose derivatives include methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose and sodium hydroxymethylcellulose. Surfactants include ionic or nonionic surfactants such as polyoxyethylene alkyl esters, sorbitan monoacyl esters, and fatty acid glycerides. Additive buffers can include boric acid, phosphoric acid, acetic acid, citric acid, glutamic acid and corresponding salts (their alkali metal or alkaline rare earth metal salts, such as sodium salts, potassium salts, calcium salts and magnesium salts). Isotonic agents include potassium chloride, sodium chloride, sugars and glycerol. Chelating agents include sodium EDTA and citric acid.

[0105] In one embodiment of the present invention, the pharmaceutical composition can be a dosage form suitable for injection, a dosage form suitable for oral administration (such as solid dosage form, liquid dosage form, emulsion, suspension), an ointment, cream or lotion form suitable for topical administration, a delivery form suitable for use as eye drops, an aerosol form suitable for administration by inhalation (such as by intranasal inhalation or oral inhalation), a dosage form suitable for parenteral administration, i.e., subcutaneous, intramuscular or intravenous injection.

[0106] Solid dosage forms for oral administration may include acceptable adhesives, sweeteners, disintegrants, diluents, flavoring agents, coating agents, preservatives, lubricants and / or time delay agents (time delay agents) in human and veterinary pharmaceutical practices. Suitable adhesives include gum arabic, gelatin, corn starch, gum tragacanth, sodium alginate, carboxymethyl cellulose or polyethylene glycol. Suitable sweeteners include sucrose, lactose, glucose, aspartame or saccharin. Suitable disintegrants include corn starch, methylcellulose, polyvinyl pyrrolidone, guar gum, xanthan gum, bentonite, alginic acid or agar. Suitable diluents include lactose, sorbitol, mannitol, dextrose, kaolin, cellulose, calcium carbonate, calcium silicate or dicalcium phosphate. Suitable flavoring agents include peppermint oil, wintergreen oil, cherry, citrus or raspberry flavoring agents. Suitable coating agents include polymers or copolymers of acrylic acid and / or methacrylic acid and / or their esters, wax, fatty alcohol, zein, shellac or gluten. Suitable preservatives include sodium benzoate, vitamin E, alpha-tocopherol, ascorbic acid, methylparaben, propylparaben or sodium bisulfite. Suitable lubricants include magnesium stearate, stearic acid, sodium oleate, sodium chloride or talc. Suitable time delay agents include glyceryl monostearate or glyceryl distearate.

[0107] Liquid dosage forms for oral administration may also include liquid carriers in addition to the above-mentioned drugs. Suitable liquid carriers include water, oils such as olive oil, peanut oil, sesame oil, sunflower oil, safflower oil, peanut oil, coconut oil, liquid paraffin, ethylene glycol, propylene glycol, polyethylene glycol, ethanol, propanol, isopropanol, glycerol, fatty alcohol, triglyceride or a mixture thereof.

[0108] Suspensions for oral administration may further include dispersants and / or suspending agents. Suitable suspending agents include sodium carboxymethylcellulose, methylcellulose, hydroxypropyl methylcellulose, polyvinyl pyrrolidone, sodium alginate or acetylethanol. Suitable dispersants include lecithin, polyoxyethylene esters of fatty acids such as stearic acid, polyoxyethylene sorbitol mono- or di-oleate, -stearate or -laurate, polyoxyethylene sorbitan mono- or di-oleate, -stearate or -laurate and the like.

[0109] The invention will be further described below in conjunction with specific examples. It should be understood that the specific embodiments described herein are presented by way of example and are not intended to limit the invention. The main features of the invention may be used in a variety of embodiments without departing from the scope of the invention.

[0110] Example 1 Isolation and purification steps of endophytic fungi

[0111] Rinse the fruit of Migao with tap water, dry the surface water with sterile filter paper, transfer to the clean bench, soak in 75% alcohol for 1 min, rinse with sterile water 3 times, then soak in 5% available chlorine for 3 min, soak in 75% alcohol for 30 s, rinse with sterile water 5 times, and dry with sterile filter paper.

[0112] After disinfection, cut the fruit into 1-2 cm tissue blocks using a sterile scalpel.

[0113] Then, the tissue blocks were gently picked up with sterile forceps and inoculated on the surface of PDA culture medium. Six tissue blocks were inoculated in each culture medium, and each method was repeated 5 times, for a total of 40 culture medium plates.

[0114] Seal the inoculated culture medium and transfer it to an incubator for constant temperature culture at 28°C.

[0115] Apply an appropriate amount of the last sterile water rinse solution on the surface of the PDA culture medium and place it in the incubator to observe whether there is growth of microbial colonies. Observe its growth status. If any contaminated or necrotic samples are found, remove them from the incubator and record them.

[0116] After hyphae grow around the plant tissue, the tips of the hyphae are picked and transferred to new PDA medium for purification. The purification is repeated 2 to 3 times until a single strain is obtained.

[0117] Example 2 Identification of endophytic fungi in Rhizoma Cibotii fruit

[0118] Refer to "Fungal Taxonomy", "Fungal Identification Manual", Species 2000 Node, and "Chinese Fungi" to observe the colony shape, color, and hyphae morphology of strains MGF21 and MGF29 on PDA plate culture medium; at the same time, take MGF21 and MGF29 plates, use a dissecting needle to pick up a small amount of hyphae from the edge of the endophytic fungus and place it on a slide with glycerol solution, separate the hyphae with a dissecting needle, and cover with a coverslip. Observe the color of the hyphae, whether there are septa and branches, shape, spore morphology and other characteristics under an optical microscope to preliminarily determine the taxonomic status of the above strains. The colony and hyphae morphology of MGF21 and MGF29 are as follows Figure 1 shown.

[0119] The two fungi were prepared into bacterial suspensions, and then sterilized 40% to 50% glycerol was used as a protective agent to prevent the protoplasm and cell membrane of the strains from being damaged. They can be stored in a -80°C refrigerator for 3-5 years. In this study, water and glycerol were mixed in a ratio of 3:7, sterilized at 121°C for 20 minutes, and then transferred to a clean bench to mix the bacterial suspension of the strain to be preserved with 70% glycerol in equal volumes in a strain preservation tube and stored in a -80°C refrigerator.

[0120] The fungal ITS universal primers ITS1-F (5'-TCCGTAGGTGAACCTGCGG-3') and ITS4-R (5'-TCCTCCGCTTATTGATATGC-3') were used to amplify the rDNA-ITS region of the strain by PCR. The amplification program was as follows: a. 94℃ pre-denaturation for 2min; b. 34 cycles (94℃ denaturation for 30sec, 55℃ annealing for 30sec, 72℃ extension for 30sec); c. 72℃ extension for 2min, -20℃ storage for later use. The electrophoresis results of the PCR amplification products detected by 1% agarose gel electrophoresis were observed by gel imaging system, and the qualified PCR products were sequenced. The PCR reaction system is shown in Table 1.

[0121] Table 1 PCR reaction system

[0122]

[0123] MGF21 sequence:

[0124] (SEQ ID NO: 1); MGF29 sequence:

[0125] (SEQ ID NO:2).

[0126] The phylogenetic tree of endophytic fungi MGF21 and MGF29 was constructed by BLAST analysis and comparison with the sequences in GenBank using MEGA7 software. It was found that the similarity between the two endophytic fungi MGF21 and MGF29 and Diaporthe biconispora (KT459418.1) was less than 98%. Combined with the morphological characteristics, MGF21 and MGF29 were preliminarily identified as new strains of the genus Diaporthe ( Figure 2 ).

[0127] Embodiment 3 Detection of volatile oil in Migao fruit

[0128] Fresh Mi Gao fruit and two strains were separated to obtain plate mycelium, which was then freeze-dried and crushed, and then the following steps were followed:

[0129] Weigh 3-5 g of the dried strain or fruit, place it in the sampling bottle of the solid phase microextraction instrument, insert a manual injector equipped with a 2 cm-50 / 30 μm DVB / CAR / PDMS StableFlex fiber head, perform headspace extraction for 50 min under flat plate heating conditions at 55 °C, remove the extraction head and immediately insert it into the gas chromatograph injection port (temperature 250 °C) for thermal decomposition injection.

[0130] Instrument: HP6890 / 5975C GC / MS (Agilent Technologies, USA).

[0131] The chromatographic column is a HP-5MS (60m×0.25mm×0.25μm) elastic quartz capillary column, with an initial temperature of 40°C (retained for 2min), heated to 208°C at 3.5°C·min-1, and then heated to 310°C at 10°C / ·min-1, running time: 60.2min; vaporization chamber temperature 250°C; carrier gas is high-purity He (99.999%); column head pressure 15.98psi, carrier gas flow rate 1.0mL·min-1, no split, solvent delay time: 3min.

[0132] The ion source is an EI source; the ion source temperature is 230°C; the quadrupole temperature is 150°C; the electron energy is 70eV; the emission current is 34.6μA; the multiplier voltage is 1824V; the interface temperature is 280°C; and the mass range is 29 to 500amu.

[0133] The peaks in the total ion current were retrieved by mass spectrometry computer data system and compared with Nist20 and Wiley275 standard mass spectra to determine the volatile chemical components of each part. The relative mass fraction of each chemical component was determined by peak area normalization method.

[0134] The main components of the volatile oil of Migao fruit, α-pinene, 1,8-cineole, elemenol, and α-terpineol, were detected in MGF21 and MGF29, and the relative percentages were not less than 1% ( Figure 3 ).

[0135] Example 4 Antibacterial Activity Experiment

[0136] Test pathogens: Neofusicoccum parvum (MGF1003), Botryosphaeria dothidea (MGF1004) and Fusarium sp. YYH2005 (MGF1005).

[0137] Endophytic fungi and pathogens of rice cakes cultured at 28℃ for 7 days were made into 6mm diameter cakes and inoculated into 4-partition culture dishes with PDA culture medium. Pathogens and endophytic fungi were inoculated into two of the 4 compartments of the culture medium at the same distance in the culture medium, and the remaining two compartments were inoculated with pathogens and endophytic fungi separately as the control group, with 3 replicates for each group. The culture was placed at 28℃ constant temperature, and the antibacterial effect was observed day by day, and the endophytic fungi with inhibitory effect were selected for the next experiment.

[0138] After the above confrontation culture, the antagonistic bacteria with antagonistic activity were screened out for the next antibacterial test. The antagonistic bacteria and pathogenic bacteria were made into 5 mm cakes and inoculated at two points 2 cm from the center of the PDA plate. Three replicates were set up, and the plate inoculated only with pathogenic bacteria was used as a control.

[0139] Endophytic fungi detected by the confrontation method with antibacterial effect were cultured in PDB medium at 28℃, 120r / min for 7 days, and the fermentation liquid was collected and centrifuged at 10000rpm, 4℃ for 10min in a high-speed refrigerated centrifuge, and the supernatant was collected and filtered through a 0.22μm filter membrane. 100μL of the fermentation liquid was evenly applied to the PDA plate with a pipette, and after it was slightly dried, a 6mm antagonistic bacterial cake was inoculated in the center of the PDA plate coated with the fermentation liquid, and the plate without fermentation liquid was used as the control. After the mycelium of the control group grew all over the dish, the colony diameter was measured by the cross method. Each fermentation broth was repeated 3 times and the average value was taken to calculate the inhibition rate. The results showed that MGF21 and MGF29 had good antibacterial activity against Neofusicoccum sp.LH107 (MGF1002), Neofusicoccum parvum (MGF1003), Botryosphaeria dothidea (MGF1004) and Fusarium sp.YYH2005 (MGF1005). Figure 4 , Table 2).

[0140] Table 2 Antibacterial activity results of endophytic fungi MGF21 and MGF29 in rice pudding fruit

[0141]

[0142] Note: The numbers in the table represent the width of the inhibition zone (mm), - means no inhibition zone, except Diaporthe sp.MGF21 and Diaporthe sp.MGF29, the rest are control strains.

[0143] The description of the above embodiments is only used to understand the method and core idea of ​​the present invention. It should be pointed out that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principle of the present invention, and these improvements and modifications will also fall within the scope of protection of the claims of the present invention.

Claims

1. An endophytic fungus in rice fruit, characterized in that: The endophytic fungus is deposited in the China Center for Type Culture Collection, with the deposit number being CCTCC NO: M 20231458. Diaporthe sp . MGF21 or strain with the deposit number of CCTCC NO: M20231459 Diaporthe sp. MGF29.

2. A culture comprising the endophytic fungus of claim 1.

3. Use of the endophytic fungus according to claim 1 or the culture according to claim 2 in the preparation of volatile oil, wherein the volatile oil is one or more of α-pinene, 1,8-cineole, elemenol or α-terpineol.

4. Use of the endophytic fungus according to claim 1 or the culture according to claim 2 in the preparation of an agent for resisting pathogenic bacteria, wherein the pathogenic bacteria is Neofusicoccum parvum , Botryosphaeria dothidea , Fusarium sp. YYH2005 or Neofusicoccum sp. One or more of LH107.

5. A method for inhibiting pathogenic bacteria, characterized in that: The method comprises administering the endophytic fungus of claim 1 or the culture of claim 2, The pathogen is Neofusicoccum parvum , Botryosphaeria dothidea , Fusarium sp. YYH2005 or Neofusicoccum sp. One or more of LH107.